Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessiongppatl21rdi95jitd568m0kmdnufn63a): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
41 results match your criteria: "Centre Hospitalier Universitaire Saint-Antoine[Affiliation]"
Crit Care
May 2023
Service de Médecine Intensive Réanimation, Département Médico-Universitaire APPROCHES, Centre Hospitalier Universitaire Tenon, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.
J Fungi (Basel)
November 2022
Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire Saint-Antoine, Assistance Publique-Hôpitaux de Paris, 184 rue du Faubourg Saint-Antoine, 75012 Paris, France.
Mycetoma is a chronic, disabling infection caused by fungi or actinomycetes that affects the disadvantaged rural populations of arid tropical regions. The identification of etiological agents is long, difficult, and often imprecise or unsuccessful. Recently developed molecular methods can be used to identify causal agents at the species level.
View Article and Find Full Text PDFArthritis Rheumatol
March 2023
Assistance Publique-Hôpitaux de Paris, Unité de Recherche Clinique, Centre Hospitalier Universitaire Fernand-Widal, Paris, France.
Objective: To determine whether a single session of botulinum toxin type A (BTA) injections into both hands more effectively decreases the frequency of systemic sclerosis-associated Raynaud's phenomenon (SSc-RP) episodes than placebo.
Methods: This multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III trial in patients with SSc-RP assessed the effect of 50-unit BTA or placebo injections into the palms of both hands around each neurovascular bundle during 1 session in winter. The primary end point was the between-group difference in the median change in the number of RP episodes from baseline (day 0) to 4 weeks postinjection.
J Rheumatol
January 2023
F. Fayet, BSc, M. Soubrier, MD, PhD, M. Rodère, BSc, Service de Rhumatologie, Centre Hospitalier Universitaire Gabriel-Montpied, Clermont-Ferrand.
Objective: To develop and validate a patient knowledge questionnaire regarding axial spondyloarthritis (axSpA).
Methods: Knowledge considered essential for patients with axSpA was identified through Delphi rounds among rheumatologists, healthcare professionals (HCPs), and patients, then reformulated to develop the knowledge questionnaire. Cross-sectional validation was performed in 14 rheumatology departments to assess internal validity (Kuder-Richardson coefficient), external validity, acceptability, reproducibility (Lin concordance correlation coefficient), and sensitivity to change (knowledge score before vs after patient education sessions and effect size).
Rheumatol Int
October 2022
Rheumatology Department, Sorbonne Université, Centre Hospitalier Universitaire Saint Antoine, Assistance Publique Hôpitaux de Paris, APHP, Paris, France.
To develop and validate a questionnaire assessing patient knowledge in rheumatoid arthritis (RA). Knowledge considered essential for patients with RA was identified through a series of Delphi rounds among rheumatologists, health professionals (HPs), patients, and then reformulated to construct the knowledge questionnaire. Cross-sectional multicenter validation was performed in 12 rheumatology departments to assess internal validity (Kuder-Richardson coefficient), external validity, acceptability, reproducibility (Lin's concordance correlation coefficient) and sensitivity to change (difference in total score before and after patient education sessions).
View Article and Find Full Text PDFRMD Open
March 2022
INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, France.
Objective: To evaluate the effect of a nurse-led patient education on safety skills of patients with inflammatory arthritis treated with biologic disease-modifying antirheumatic drugs (bDMARDs).
Methods: This is a multicentre, open-labelled, randomised controlled trial comparing an intervention group (face-to-face education by a nurse at baseline and 3 months later) with a control group (usual care) at the introduction of a first subcutaneous bDMARD. The primary outcome was score on the BioSecure questionnaire at 6 months (0-100 scale), a validated questionnaire assessing competencies in dealing with fever, infections, vaccination and daily situations.
Joint Bone Spine
October 2021
Service de Rhumatologie, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France.
J Clin Oncol
January 2021
Frederiek Nuytens, MD, Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, Lille, France; Thibault Voron, MD, PhD, Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, Lille, France, and Department of General and Digestive Surgery, Centre Hospitalier Universitaire Saint-Antoine, Sorbonne University, Paris, France; and Guillaume Piessen, MD, PhD, Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, Lille, France, and University Lille, Centre National de la Recherche Scientifique, INSERM, Centre Hospitalier Universitaire Lille, UMR9020-U1277, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
Acta Neurol Belg
December 2020
Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, 78150, Le Chesnay, France.
Tiagabine-related status epilepticus (SE) is an uncommon complication of tiagabine use. We aimed to detail the features and outcomes in a patient with tiagabine poisoning and review the relevant literature. We describe a case of tiagabine-related SE and literature review based on a 1995-2019 PubMed search.
View Article and Find Full Text PDFJoint Bone Spine
October 2020
Department of Rheumatology, Hôpital Nord, CHU Saint-Étienne, Inserm U1059, Université de Lyon-Université Jean-Monnet, Saint-Étienne, France. Electronic address:
Background: Rheumatologists must contend with COVID-19 pandemic in the management of their patients and many questions have been raised on the use of both anti-inflammatory drugs and disease-modifying anti-rheumatic drugs (DMARD). The French Society of Rheumatology (SFR) selected the most critical ones to the daily practice of a rheumatologist and a group of 10 experts from SFR and Club Rheumatism and Inflammation (CRI) boards proposed responses based on the current knowledge of May 2020.
Methods: Following the availability of the first 18 questions and statements, 1400 individuals consulted the frequently asked questions between the March 31, 2020 and April 12, 2020.
Joint Bone Spine
December 2020
Service de Rhumatologie, Centre hospitalier Universitaire Salengro, Université de Lille, 59037 Lille Cedex, France.
Br J Clin Pharmacol
November 2020
Centre Anti-Poison et de Toxicovigilance de Paris - Fédération de toxicologie, Assistance Publique des Hôpitaux de Paris, Hôpital Fernand-Widal, Paris, France.
Aims: Amoxicillin (AMX)-induced crystal nephropathy (AICN) is a rarely reported adverse drug reaction (ADR) but its increase has been recently reported in the Paris area. Our aim was to investigate the incidence, characteristics and outcome of AICN in France.
Methods: Retrospective analysis of all AICN cases reported to the French National Pharmacovigilance Database and the Marketing Authorization Holders Pharmacovigilance Database.
Joint Bone Spine
November 2019
Sorbonne université, Institut Pierre-Louis d'Épidémiologie et de santé publique (iPLESP), UMR S1136, Paris, France; Service de rhumatologie, centre hospitalier universitaire Pitié Salpêtrière, AP-HP, Paris, France.
Objective: Information and education are recommended for patients with inflammatory arthritis including rheumatoid arthritis (RA) and spondyloarthritis (SpA). However, there is no consensus on which knowledge is essential to enhance patients' self-management. The aim of this study was to determine such knowledge.
View Article and Find Full Text PDFAnn Intensive Care
September 2018
Service de Réanimation Polyvalente, Centre Hospitalier Victor Dupouy, 69 rue du Lieutenant Colonel Prudhon, 95100, Argenteuil, France.
Background: Anti-synthetase (AS) and dermato-pulmonary associated with anti-MDA-5 antibodies (aMDA-5) syndromes are near one of the other autoimmune inflammatory myopathies potentially responsible for severe acute interstitial lung disease. We undertook a 13-year retrospective multicenter study in 35 French ICUs in order to describe the clinical presentation and the outcome of patients admitted to the ICU for acute respiratory failure (ARF) revealing AS or aMDA-5 syndromes.
Results: From 2005 to 2017, 47 patients (23 males; median age 60 [1st-3rd quartiles 52-69] years, no comorbidity 85%) were admitted to the ICU for ARF revealing AS (n = 28, 60%) or aMDA-5 (n = 19, 40%) syndromes.
Blood
November 2018
Centre de Référence des Microangiopathies Thrombotiques, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
Br J Haematol
June 2018
Sorbonne Universités, UPMC Univ Paris 06, Institut de Cardiologie (AP-HP), Centre Hospitalier Universitaire Pitié-Salpêtrière, Institute of Cardiometabolism and Nutrition (ICAN), INSERM UMRS 1166, ACTION Study Group, Paris, France.
Cardiac involvement is well characterized in sickle cell anaemia (SCA) but cardiac features associated with Haemoglobin SC (HbSC) disease are mostly unknown. We compared 60 patients with HbSC disease (median age 31 years, 25 men) to 60 SCA patients and 60 controls matched for age and gender. Left ventricular ejection fraction (LVEF), left ventricle (LV) mass index (LVMi), cardiac index and peak tricuspid regurgitation velocity (TRV) were measured using echocardiography.
View Article and Find Full Text PDFOcul Immunol Inflamm
January 2020
d Department of Internal Medicine, Centre Hospitalier Universitaire Saint-Antoine, Paris Cedex 12 , France.
: To report low-dose rituximab effect in Graves' orbitopathy (GO) resistant to conventional treatment. : Retrospective analysis of medical records, filled in according to the European Group on Graves' Orbitopathy (EUGOGO) standards, of patients with active moderate-to-severe GO who received low-dose rituximab after failure of conventional treatment. Efficacy was defined by a decrease of the clinical activity score of 2 points or <4/10.
View Article and Find Full Text PDFSarcoidosis Vasc Diffuse Lung Dis
March 2020
Service de Médecine Interne, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France, Université Claude Bernard Lyon 1, Villeurbanne, France.
Tumor necrosis factor (TNF) antagonists have been reported as an efficient third-line therapy for sarcoidosis but there is no data regarding patients who do not respond to this treatment. To report the characteristics, the outcome and the response to therapy of patients with sarcoidosis resistant to TNF antagonists. Patients from the French STAT (Sarcoidosis Treatment with Anti-TNF) registry who were classified as non-responders and who were followed-up for >1 year were included.
View Article and Find Full Text PDFThromb Res
October 2017
Hematology Laboratory, Toulouse University Hospital, Toulouse, France.
Unlabelled: Dabigatran etexilate, rivaroxaban and apixaban (DOACs) are widely used and measurement of their concentration is desirable in certain clinical situations. Target-specific assays are available but limited information exists on their performance especially in their ability to accurately measure low and high concentrations.
Aims: To define, in a multicenter study, the precision and accuracy of DOAC measurements in daily practice.
J Mycol Med
December 2016
Centre hospitalier universitaire Necker-Enfants-Malades, Assistance publique-Hôpitaux de Paris, laboratoire de parasitologie-mycologie, 149, rue de Sèvres, 75015 Paris, France.
Objective Of The Study: An estimation of burden of serious fungal diseases in France is essential data to inform public health priorities on the importance of resources and research needed on these infections. In France, precise data are available for invasive fungal diseases but estimates for several other diseases such as chronic and immunoallergic diseases are by contrast less known.
Materials And Methods: A systematic literature search was conducted using the Web of Science Platform.
Crit Care
November 2016
Service de réanimation Médicale, Groupe de Recherche CARMAS, Centre Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris, 51, avenue du Maréchal de Lattre de Tassigny, Créteil, 94010, France.
Background: The lack of a patent source of infection after 24 hours of management of shock considered septic is a common and disturbing scenario. We aimed to determine the prevalence and the causes of shock with no diagnosis 24 hours after its onset, and to compare the outcomes of patients with early-confirmed septic shock to those of others.
Methods: We conducted a pragmatic, prospective, multicenter observational cohort study in ten intensive care units (ICU) in France.
J Clin Microbiol
July 2015
Centre Hospitalier Universitaire Grenoble, Pôle Biologie, Laboratoire de Virologie, Département des Agents Infectieux, Grenoble, France Université Grenoble Alpes, Unit of Virus Host Cell Interactions UMI 3265 UJF-EMBL-CNRS, Grenoble, France.
The pretherapeutic presence of protease inhibitor (PI) resistance-associated variants (RAVs) has not been shown to be predictive of triple-therapy outcomes in treatment-naive patients. However, they may influence the outcome in patients with less effective pegylated interferon (pegIFN)-ribavirin (RBV) backbones. Using hepatitis C virus (HCV) population sequence analysis, we retrospectively investigated the prevalence of baseline nonstructural 3 (NS3) RAVs in a multicenter cohort of poor IFN-RBV responders (i.
View Article and Find Full Text PDFInteract Cardiovasc Thorac Surg
June 2015
Department of Thoracic Surgery, Aix Marseille University, Assistance Publique - Hôpitaux de Marseille, Marseille, France
Objectives: Adjuvant chemotherapy with vinorelbine plus cisplatin (VC) improves survival in resected non-small-cell lung cancer (NSCLC), but has negative impact on quality of life (QoL). In advanced NSCLC, gemcitabine plus cisplatin (GC) and docetaxel plus cisplatin (DC) exhibit comparable efficacy, with possibly superior QoL compared to VC. This trial investigated these regimens in the adjuvant setting.
View Article and Find Full Text PDFTherapie
September 2006
AP-HP Pharmacie, Centre Hospitalier Universitaire Saint-Antoine, Paris, France.
Our objective was to analyse economic consequences modifying first line chemotherapy in treatment non small cell lung cancer IIIB-IV. Therefore a cost minimisation has been performed. Resources consumption were collected in a Pneumology department for 21 patients receiving previously mitomycine-ifosfamide-platin and for the 21 first patients receiving vinorelbine-platin, new patients diagnosed during year 2001.
View Article and Find Full Text PDFJ Am Soc Nephrol
August 2005
Address correspondence to: Dr. Pierre J. Verroust, INSERM U538, Centre Hospitalier Universitaire Saint Antoine, 27 Rue Chaligny, 75012 Paris, France.
Cubilin is a peripheral apical membrane receptor for multiple ligands that are taken up in several absorptive epithelia. Recently, amnionless (AMN) was identified to form a functional receptor complex with cubilin. By expression in transfected polarized MDCK cells of AMN and several cubilin fragments, including a functional "mini" version of cubilin, the processing, sorting, and membrane anchoring of the complex to the apical membrane were investigated.
View Article and Find Full Text PDF